Article Excerpt: The U.S. Food and Drug Administration (FDA) has recently granted Breakthrough Device status to Med-botics, LLC’s Oxalert Enhanced Pulse Oximeter (EPOTM), a wearable device designed to prevent respiratory arrest and death from an opioid overdose. This is an FDA designation that aims to expedite the development, assessment, and review of medical devices that may be more effective than current options in treating/diagnosing life-threatening or irreversibly debilitating conditions.
Full Article: https://tinyurl.com/y4dmzelp
Article Source: DocWire